Photys
Photys Therapeutics | Control of protein post-translational modifications
Waltham, United States · $75.0M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- photys.com
- Total Funding
- $75.0M
- Last Round
- $75.0M Series ASep 2022
- Rounds
- 1
About
Biotech company developing chimeric small molecules for precise protein function control, targeting oncology and autoimmune diseases.
Summary
Photys is a Biotech company based in Waltham, United States. It has raised $75.0M in total across 1 round, most recently a $75.0M Series A round in Sep 2022. Investors include MPM Capital, Omega Funds and Longwood Fund.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...